We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Longterm Outcome of Inpatient Cognitive and Behavioral Therapies for Agoraphobia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01446172
Recruitment Status : Completed
First Posted : October 5, 2011
Last Update Posted : April 23, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:

While cognitive therapy and exposure therapy are both proven to be effective for panic disorder and/or agoraphobia when outcome is assenssed up to one year after treatment (Gould et al., 1995) the scientific knowledge about long-term course of these disorders is still scanty. Although several long-term outcome studies have been conducted, the quality of these studies has been questioned.

The aim is to conduct a follow-up study of patients with either panic disorder with history of agoraphobia or agoraphobia without history of panic disorder. the patients were treated in a group format at Modum Bad during the years 1989 to 1997. Four subsamples will be included in the study. Subsample 1 (76 patients treated in 1989 and 1990) received combined cognitive and psychodynamic treatment. Subsample 2 and 3 (46 patients treated in 1992 - 1993) were allocated to either cognitive therapy or guided mastery treatment. Subsample 4 (45 patients treated in 1994 - 1996) received cognitive and schema focused therapy.

In the follow-up study the participants will be requested to complete the same self report measures as they completed at intake, discharge and at previous follow-up times. the participants will also be interviewed using the SCID-I and II as they were at the previous assessments.

The present sample is relatively unique in having received pure psychosocial experimental treatments. The very long term efficacy of cognitive therapy relative to behavioural treatmetns for agoraphobia can be evaluated, and the potential moderating effects of personality disorders can be assessed.


Condition or disease
Agoraphobia

Study Design

Study Type : Observational
Estimated Enrollment : 132 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Longterm Outcome of Inpatient Cognitive and Behavioral Therapies for Panic Disroder and Agoraphobia
Study Start Date : November 2009
Primary Completion Date : November 2010
Study Completion Date : November 2010
Groups and Cohorts

Group/Cohort
cognitive, schema focused, guided mastery, exposure


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients diagnosed with panic disorder with or without agoraphobia and/or agoraphobia without history of panic disorder who have accepted treatment at an inpatient psychiatric hospital
Criteria

Inclusion Criteria:

  • Meet the DSM-IV kriteria for either panic disorder, panic disorder with agoraphobia or agoraphobia

Exclusion Criteria:

  • psychosis
  • dementia
  • substance abuse
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01446172


Locations
Norway
Modum Bad
Vikersund, Norway
Sponsors and Collaborators
Modum Bad
More Information

Responsible Party: Modum Bad
ClinicalTrials.gov Identifier: NCT01446172     History of Changes
Other Study ID Numbers: Hedley-1
First Posted: October 5, 2011    Key Record Dates
Last Update Posted: April 23, 2012
Last Verified: April 2012

Keywords provided by Modum Bad:
Long term outcome

Additional relevant MeSH terms:
Agoraphobia
Anxiety Disorders
Mental Disorders